Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

NCT05484973 · View on ClinicalTrials.gov ↗

Study Summary

The purpose of this prospective study is to assess the ability of AMMA to prevent hair loss in women receiving chemotherapy (CT) for early-stage breast cancer. Additionally, the purpose is also to assess the safety, tolerability and compliance, quality of life, and satisfaction with hair preservation after CT treatment.

Interventions

  • DEVICE AMMA Portalbe Scalp Cooling System

Study Locations (2)

Arizona

  • University of Arizona — Tucson

Illinois

  • Carle Health — Urbana

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2024-11-08
Est. Completion 2026-09-30
Phase NA

Sponsor

Cooler Heads Care

1 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05484973

The ClinicalTrials.gov registry entry for NCT05484973 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cooler Heads Care, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention — of which AMMA Portalbe Scalp Cooling System is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT05484973 reports 2 study locations spanning 2 distinct geographic areas — top geographies include Arizona, Illinois. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT05484973 about?

NCT05484973 is a clinical study titled "Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss". The purpose of this prospective study is to assess the ability of AMMA to prevent hair loss in women receiving chemotherapy (CT) for early-stage breast cancer. Additionally, the purpose is also to assess the safety, tolerability and compliance, quality of life, and satisfaction with hair preservatio...

What is the current status of trial NCT05484973?

This trial is currently recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2024-11-08. Estimated completion is 2026-09-30.

What conditions does trial NCT05484973 study?

This clinical trial studies the following conditions: Breast Cancer, Alopecia, Hair Loss, Chemotherapy-induced Alopecia. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT05484973?

The interventions under investigation include: AMMA Portalbe Scalp Cooling System (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT05484973?

This trial is sponsored by Cooler Heads Care, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT05484973 being conducted?

This trial has 2 study locations across Arizona, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial